{
    "organizations": [],
    "uuid": "4b96cec9caa6075d7214be837f4b78a2b2e4e979",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-delivra-says-announced-ability-to/brief-delivra-says-announced-ability-to-treat-pain-directly-with-a-topical-version-of-advil-idUSFWN1S10NM",
    "ord_in_thread": 0,
    "title": "BRIEF-Delivra Says Announced Ability To Treat Pain Directly With A Topical Version Of Advil",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": " Delivra Corp:\n* DELIVRA CORP - ANNOUNCED ABILITY TO TREAT PAIN DIRECTLY WITH A TOPICAL VERSION OF ADVIL (IBUPROFEN)\n* DELIVRA CORP - IN PRE-CLINICAL TESTING, DELIVRA-IBUPROFEN FORMULATION PROVIDED SUSTAINED PAIN REDUCTION Source text for Eikon: Further company coverage:\n ",
    "published": "2018-04-24T19:12:00.000+03:00",
    "crawled": "2018-04-25T14:14:58.004+03:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "delivra",
        "corp",
        "delivra",
        "corp",
        "announced",
        "ability",
        "treat",
        "pain",
        "directly",
        "topical",
        "version",
        "advil",
        "ibuprofen",
        "delivra",
        "corp",
        "testing",
        "formulation",
        "provided",
        "sustained",
        "pain",
        "reduction",
        "source",
        "text",
        "eikon",
        "company",
        "coverage"
    ]
}